268 related articles for article (PubMed ID: 16473372)
21. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
Jellinger KA; Attems J
Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
[TBL] [Abstract][Full Text] [Related]
22. Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease.
Puig B; Vinals F; Ferrer I
Acta Neuropathol; 2004 Mar; 107(3):185-9. PubMed ID: 14689204
[TBL] [Abstract][Full Text] [Related]
23. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
24. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.
Kersaitis C; Halliday GM; Kril JJ
Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
[TBL] [Abstract][Full Text] [Related]
26. Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies.
Schwab C; McGeer PL
Exp Neurol; 2000 Feb; 161(2):527-34. PubMed ID: 10686074
[TBL] [Abstract][Full Text] [Related]
27. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.
Delacourte A; Sergeant N; Wattez A; Gauvreau D; Robitaille Y
Ann Neurol; 1998 Feb; 43(2):193-204. PubMed ID: 9485060
[TBL] [Abstract][Full Text] [Related]
28. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
[TBL] [Abstract][Full Text] [Related]
29. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
[TBL] [Abstract][Full Text] [Related]
30. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.
Fujino Y; Delucia MW; Davies P; Dickson DW
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):676-82. PubMed ID: 15541007
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain.
Distl R; Treiber-Held S; Albert F; Meske V; Harzer K; Ohm TG
J Pathol; 2003 May; 200(1):104-11. PubMed ID: 12692848
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
35. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
36. Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.
King ME; Ghoshal N; Wall JS; Binder LI; Ksiezak-Reding H
Am J Pathol; 2001 Apr; 158(4):1481-90. PubMed ID: 11290566
[TBL] [Abstract][Full Text] [Related]
37. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
Bronner IF; ter Meulen BC; Azmani A; Severijnen LA; Willemsen R; Kamphorst W; Ravid R; Heutink P; van Swieten JC
Brain; 2005 Nov; 128(Pt 11):2645-53. PubMed ID: 16014652
[TBL] [Abstract][Full Text] [Related]
38. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
39. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
